Principal Financial Group’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $17.6M | Buy |
341,117
+15,078
| +5% | +$768K | 0.01% | 994 |
|
|
2025
Q4 | $16.2M | Buy |
326,039
+22,631
| +7% | +$1.1M | 0.01% | 1016 |
|
|
2025
Q3 | $14.5M | Sell |
303,408
-2,223
| -0.7% | -$89.5K | 0.01% | 1050 |
|
|
2025
Q2 | $9.63M | Sell |
305,631
-691
| -0.2% | -$22.1K | 0.01% | 1290 |
|
|
2025
Q1 | $10M | Buy |
306,322
+9,590
| +3% | +$340K | 0.01% | 1259 |
|
|
2024
Q4 | $10.7M | Buy |
296,732
+11,321
| +4% | +$399K | 0.01% | 1258 |
|
|
2024
Q3 | $8.9M | Buy |
285,411
+14,566
| +5% | +$455K | ﹤0.01% | 1344 |
|
|
2024
Q2 | $7.25M | Sell |
270,845
-13,151
| -5% | -$381K | ﹤0.01% | 1423 |
|
|
2024
Q1 | $9.69M | Sell |
283,996
-16,447
| -5% | -$490K | 0.01% | 1326 |
|
|
2023
Q4 | $8.69M | Sell |
300,443
-3,337
| -1% | -$88.5K | 0.01% | 1358 |
|
|
2023
Q3 | $8.38M | Sell |
303,780
-13,816
| -4% | -$421K | 0.01% | 1321 |
|
|
2023
Q2 | $9.55M | Sell |
317,596
-16,835
| -5% | -$589K | 0.01% | 1277 |
|
|
2023
Q1 | $12.1M | Sell |
334,431
-5,205
| -2% | -$200K | 0.01% | 1156 |
|
|
2022
Q4 | $12.1M | Sell |
339,636
-3,224
| -0.9% | -$112K | 0.01% | 1136 |
|
|
2022
Q3 | $11.6M | Sell |
342,860
-23,531
| -6% | -$766K | 0.01% | 1106 |
|
|
2022
Q2 | $10.6M | Sell |
366,391
-28,405
| -7% | -$814K | 0.01% | 1221 |
|
|
2022
Q1 | $12.8M | Sell |
394,796
-21,458
| -5% | -$658K | 0.01% | 1235 |
|
|
2021
Q4 | $12.1M | Sell |
416,254
-38,102
| -8% | -$1.16M | 0.01% | 1283 |
|
|
2021
Q3 | $12.1M | Buy |
454,356
+743
| +0.2% | +$19.9K | 0.01% | 1299 |
|
|
2021
Q2 | $14M | Buy |
453,613
+23,232
| +5% | +$712K | 0.01% | 1239 |
|
|
2021
Q1 | $11.3M | Buy |
430,381
+6,399
| +2% | +$179K | 0.01% | 1335 |
|
|
2020
Q4 | $10.7M | Buy |
423,982
+45,191
| +12% | +$973K | 0.01% | 1187 |
|
|
2020
Q3 | $7.89M | Sell |
378,791
-15,712
| -4% | -$357K | 0.01% | 1209 |
|
|
2020
Q2 | $9.37M | Sell |
394,503
-4,058
| -1% | -$89.7K | 0.01% | 1094 |
|
|
2020
Q1 | $7.17M | Sell |
398,561
-17,597
| -4% | -$370K | 0.01% | 1093 |
|
|
2019
Q4 | $9.87M | Sell |
416,158
-33,489
| -7% | -$813K | 0.01% | 1260 |
|
|
2019
Q3 | $12.4M | Buy |
449,647
+4,347
| +1% | +$129K | 0.01% | 1091 |
|
|
2019
Q2 | $14.7M | Sell |
445,300
-16,980
| -4% | -$582K | 0.01% | 1005 |
|
|
2019
Q1 | $16.2M | Sell |
462,280
-2,401
| -0.5% | -$89.3K | 0.02% | 928 |
|
|
2018
Q4 | $15.4M | Buy |
464,681
+12,084
| +3% | +$520K | 0.02% | 878 |
|
|
2018
Q3 | $22.8M | Buy |
452,597
+20,530
| +5% | +$1.01M | 0.02% | 770 |
|
|
2018
Q2 | $25.9M | Buy |
432,067
+9,005
| +2% | +$466K | 0.02% | 663 |
|
|
2018
Q1 | $19.4M | Buy |
423,062
+13,238
| +3% | +$552K | 0.02% | 804 |
|
|
2017
Q4 | $16.3M | Buy |
409,824
+3,049
| +0.7% | +$120K | 0.02% | 962 |
|
|
2017
Q3 | $16.3M | Sell |
406,775
-1,903
| -0.5% | -$82.4K | 0.02% | 930 |
|
|
2017
Q2 | $17.6M | Sell |
408,678
-564
| -0.1% | -$20.1K | 0.02% | 849 |
|
|
2017
Q1 | $12.8M | Buy |
409,242
+17,864
| +5% | +$479K | 0.02% | 1041 |
|
|
2016
Q4 | $9.88M | Buy |
391,378
+17,415
| +5% | +$389K | 0.01% | 1173 |
|
|
2016
Q3 | $9.25M | Buy |
373,963
+129,102
| +53% | +$2.92M | 0.01% | 1170 |
|
|
2016
Q2 | $4.99M | Buy |
244,861
+8,903
| +4% | +$158K | 0.01% | 1432 |
|
|
2016
Q1 | $3.6M | Buy |
235,958
+9,127
| +4% | +$119K | 0.01% | 1497 |
|
|
2015
Q4 | $3.05M | Buy |
226,831
+13,199
| +6% | +$204K | ﹤0.01% | 1537 |
|
|
2015
Q3 | $3M | Buy |
213,632
+39,061
| +22% | +$726K | ﹤0.01% | 1539 |
|
|
2015
Q2 | $2.96M | Buy |
+174,571
| New | +$2.48M | ﹤0.01% | 1592 |
|
Other funds holding SUPN
VPM
VCM
NAMI
AC
